Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,850.00    155.00 (2.32%)
Bid:
6,845.00
Ask:
6,855.00
Spread: 10.00 (0.146%)
Market Cap: £5.06b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 Nov 2009 07:00

RNS Number : 1535C
Spirax-Sarco Engineering PLC
09 November 2009
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Monday 9th November 2009

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the period since 1st July 2009.

Trading

Since the half year, the pace of decline in our sales has stabilised. Sales for the year to date through October were down 9% in constant currency against strong results last year. Exchange rates have continued to be favourable and have added 10% to Group revenues in 2009 compared with average exchange rates in calendar year 2008.

Trading margin this year has benefited from exchange rates and, since the end of the half year, has benefited from lower materials costs and reduced operating costs. We have completed the announced headcount reductions which, together with further attrition, means our headcount is now 7% lower than the start of the year. The reductions are largely in manufacturing and administrative support, with cost benefits in the second half year and continuing to be delivered in 2010.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 31st October 2009 of £1m despite funding the acquisition of MasoSine in August for £22m and Intervalf in October for £3m. There has been no material change in the financial position of the Group during the period. Capital investment is well above the level in recent years as we continue to invest in projects with good returns to deliver more efficient manufacturing processes and capacity expansion, particularly in developing markets.

Outlook

Our strong cash position has enabled us to continue to make investments in developing new products, expanding our market penetration and improving operating efficiency, even through this difficult period. The Group's strong customer value proposition and diversity of end user markets, customers, products and geographic spread, give us confidence in our future prospects.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,200 people, of whom 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBXUGGGCL
Date   Source Headline
25th May 201210:00 amRNSResult of AGM
22nd May 20123:20 pmRNSDirector/PDMR Shareholding
16th May 20124:45 pmRNSRe-Appointment of Non-Executive Directors
16th May 20129:13 amRNSHolding(s) in Company
15th May 20127:00 amRNSInterim Management Statement
10th May 20123:01 pmRNSHolding(s) in Company
9th May 20129:57 amRNSHolding(s) in Company
1st May 20125:03 pmRNSTotal Voting Rights
26th Apr 20123:02 pmRNSDirector/PDMR Shareholding
23rd Apr 20128:41 amRNSHolding(s) in Company
17th Apr 20122:56 pmRNSDirector/PDMR Shareholding
17th Apr 20122:14 pmRNSDirector/PDMR Shareholding
12th Apr 20128:33 amRNSHolding(s) in Company
2nd Apr 201210:05 amRNSHolding(s) in Company
27th Mar 201210:44 amRNSHolding(s) in Company
20th Mar 20125:16 pmRNSHolding(s) in Company
15th Mar 201211:00 amRNSDirector/PDMR Shareholding
15th Mar 20127:00 amRNSDirectorate Change
14th Mar 20125:17 pmRNSDirector/PDMR Shareholding
8th Mar 20127:00 amRNSPreliminary Results
1st Mar 201210:38 amRNSTotal Voting Rights
22nd Feb 20129:11 amRNSHolding(s) in Company
16th Feb 20129:09 amRNSHolding(s) in Company
8th Feb 20128:39 amRNSHolding(s) in Company
1st Feb 20121:39 pmRNSTotal Voting Rights
16th Jan 20124:49 pmRNSNotice of Results
3rd Jan 20128:53 amRNSTotal Voting Rights
19th Dec 20119:11 amRNSRe-Appointment of Non-Executive Director
12th Dec 20114:25 pmRNSDirector/PDMR Shareholding
16th Nov 20115:31 pmRNSDirector/PDMR Shareholding
4th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20114:27 pmRNSTotal Voting Rights
19th Oct 201112:00 pmRNSDirectorate Change
18th Oct 20119:28 amRNSHolding(s) in Company
17th Oct 20111:58 pmRNSHolding(s) in Company
12th Oct 20113:51 pmRNSDirector/PDMR Shareholding
11th Oct 20114:15 pmRNSTotal Voting Rights
6th Sep 20119:00 amRNSTotal Voting Rights
5th Sep 20115:02 pmRNSDirector/PDMR Shareholding
24th Aug 20114:28 pmRNSDirector/PDMR Shareholding
23rd Aug 20113:54 pmRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNS2011 Half Year Results
4th Aug 20115:32 pmRNSNotice of Results
4th Aug 20114:11 pmRNSTotal Voting Rights
27th Jul 20111:03 pmRNSAdditional Listing
12th Jul 20115:14 pmRNSDirector/PDMR Shareholding
6th Jul 20111:47 pmRNSAdditional Listing
1st Jul 201110:43 amRNSTotal Voting Rights
22nd Jun 20114:05 pmRNSDirector/PDMR Shareholding
9th Jun 20119:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.